Avidity Biosciences
RNA
#1877
Rank
A$15.70 B
Marketcap
A$104.21
Share price
0.00%
Change (1 day)
94.44%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: A$15.70 Billion

As of February 2026 Avidity Biosciences has a market cap of A$15.70 Billion. This makes Avidity Biosciences the world's 1877th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.70 B-3.23%
2025A$16.22 B180.94%
2024A$5.77 B449.14%
2023A$1.05 B-51.47%
2022A$2.16 B40.95%
2021A$1.53 B23.46%
2020A$1.24 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Avidity Biosciences was reported to be:

A$15.70 Billion
by Nasdaq info icon info icon
A$15.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$215.87 B 1,274.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$149.75 B 853.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$3.06 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.70 B-44.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.19 B-98.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.69 B-0.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.28 B-72.68%๐Ÿ‡บ๐Ÿ‡ธ USA